Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
51.18
-0.23 (-0.45%)
May 12, 2026, 3:59 PM EST
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $327.95 billion as of May 12, 2026. Its market cap has increased by 30.63% in one year.
Market Cap
327.95B
Enterprise Value
355.80B
Revenue
79.90B
Ranking
n/a
PE Ratio
20.19
Stock Price
$51.18
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 327.95B, an increase of 3,644.24%. That is a compound annual growth rate of 11.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 327.95B | -1.08% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 793.88M |
| Veradigm | 790.57M |
| Nika Pharmaceuticals | 422.78M |
| Northwest Biotherapeutics | 422.08M |
| CytoDyn | 412.04M |
| Elite Pharmaceuticals | 374.27M |
| Silence Therapeutics | 338.67M |
| American Oncology Network | 312.02M |